Author

I. Koralnik

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

L. Visvabharathy· 2 shared P. Penaloza-MacMaster· 2 shared S. Sanchez· 2 shared T. Dangi· 2 shared J. Class· 1 shared J. M. Richner· 1 shared J. Richner· 1 shared M. H. Lew· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

L. Visvabharathy

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pre-existing immunity modulates responses to mRNA boosters

T. Dangi, S. Sanchez, M. H. Lew, L. Visvabharathy, J. M. Richner, I. Koralnik, P. Penaloza-MacMaster

The paper shows pre-existing immunity affects the effectiveness of mRNA vaccine boosters, with lower pre-existing antibodies leading to greater post-booster increases and updated vaccines being more effective in certain serostatus groups.

bioRxiv · Jun 27, 2022Immunology

SARS coronavirus vaccines protect against different coronaviruses

T. Dangi, N. Palacio, S. Sanchez, J. Class, L. Visvabharathy, T. Ciucci, I. Koralnik, J. Richner, P. Penaloza-MacMaster

This study shows SARS-CoV-2 vaccines and prior coronavirus infections generate cross-reactive antibodies and T cell responses that provide protection against other coronaviruses in humans and mice.

bioRxiv · Jun 1, 2021 · PreprintImmunology